Cargando…

Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status

Type II endometrial cancer (EC) is responsible for most endometrial cancer-related deaths due to its aggressive nature, late-stage detection, and high tolerance to standard therapies. Thus, novel treatment strategies for type II EC are imperative. For patients with mismatch repair-deficient (dMMR) t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawada, Kiyoka, Nakayama, Kentaro, Razia, Sultana, Yamashita, Hitomi, Ishibashi, Tomoka, Ishikawa, Masako, Kanno, Kosuke, Sato, Seiya, Nakayama, Satoru, Otsuki, Yoshiro, Kyo, Satoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137870/ https://www.ncbi.nlm.nih.gov/pubmed/37107907 http://dx.doi.org/10.3390/healthcare11081073

Ejemplares similares

Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation
por: Sato, Seiya, et al.
Publicado: (2023)

Ovarian Endometrioid and Clear Cell Carcinomas with Low Prevalence of Microsatellite Instability: A Unique Subset of Ovarian Carcinomas Could Benefit from Combination Therapy with Immune Checkpoint Inhibitors and Other Anticancer Agents
por: Nonomura, Yuki, et al.
Publicado: (2022)

Promising Therapeutic Impact of a Selective Estrogen Receptor Downregulator, Fulvestrant, as Demonstrated In Vitro upon Low-Grade Serous Ovarian Carcinoma Cell Lines
por: Shanta, Kamrunnahar, et al.
Publicado: (2022)

Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)
por: Ono, Ruriko, et al.
Publicado: (2019)

Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study
por: Razia, Sultana, et al.
Publicado: (2023)

The Case of an Endometrial Cancer Patient with Breast Cancer Who Has Achieved Long-Term Survival via Letrozole Monotherapy
por: Ishikawa, Masako, et al.
Publicado: (2023)

P16(INK4A) expression might be associated with a favorable prognosis for cervical adenocarcinoma via dysregulation of the RB pathway
por: Ishikawa, Masako, et al.
Publicado: (2021)

Comparison between bidirectional Stratafix(®) barbed suture and conventional suture in laparoscopic myomectomy: a retrospective study
por: Nakayama, Kentaro, et al.
Publicado: (2020)

Clinical Outcomes of Genotype-Matched Therapy for Recurrent Gynecological Cancers: A Single Institutional Experience
por: Sawada, Kiyoka, et al.
Publicado: (2021)

Identifying the Carcinogenic Mechanism of Malignant Struma Ovarii Using Whole-Exome Sequencing and DNA Methylation Analysis
por: Yamashita, Hitomi, et al.
Publicado: (2023)

Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese Patients
por: Sasamori, Hiroki, et al.
Publicado: (2022)

Underdiagnosis of early cervical cancer with an invisible cervical transformation zone in an elderly patient: A case report
por: Ishikawa, Masako, et al.
Publicado: (2021)

Single-port laparoscopic surgery for ovarian cystectomy: A single-center analysis of 25 cases
por: Nakayama, Kentaro, et al.
Publicado: (2021)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

Neutropenic enterocolitis-induced sepsis and disseminated intravascular coagulation after chemotherapy: a case report
por: Ishikawa, Masako, et al.
Publicado: (2021)

Pathological findings in the endometrium after microwave endometrial ablation
por: Nakayama, Kentaro, et al.
Publicado: (2020)

High PD-1 expression level is associated with an unfavorable prognosis in patients with cervical adenocarcinoma
por: Ishikawa, Masako, et al.
Publicado: (2020)

Microsatellite instability is a biomarker for immune checkpoint inhibitors in endometrial cancer
por: Yamashita, Hitomi, et al.
Publicado: (2017)

Relationship between Microsatellite Instability, Immune Cells Infiltration, and Expression of Immune Checkpoint Molecules in Ovarian Carcinoma: Immunotherapeutic Strategies for the Future
por: Yamashita, Hitomi, et al.
Publicado: (2019)

High Frequency of PIK3CA Mutations in Low-Grade Serous Ovarian Carcinomas of Japanese Patients
por: Ishibashi, Tomoka, et al.
Publicado: (2019)

Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance
por: Kyo, Satoru, et al.
Publicado: (2022)

Whole-Exome Sequencing of Rare Site Endometriosis-Associated Cancer
por: Kurose, Sonomi, et al.
Publicado: (2021)

Prognostic Value of Peripheral Blood Lymphocyte Telomere Length in Gynecologic Malignant Tumors
por: Shanta, Kamrunnahar, et al.
Publicado: (2020)

Establishment of a Novel In Vitro Model of Endometriosis with Oncogenic KRAS and PIK3CA Mutations for Understanding the Underlying Biology and Molecular Pathogenesis
por: Hossain, Mohammad Mahmud, et al.
Publicado: (2021)

Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas
por: KATAGIRI, HIROSHI, et al.
Publicado: (2015)

Metastasis of breast cancer to an endometrial polyp, the cervix and a leiomyoma: A case report and review of the literature
por: Razia, Sultana, et al.
Publicado: (2017)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
por: Sato, Emi, et al.
Publicado: (2018)

Long-term outcomes of microwave endometrial ablation for treatment of patients with menorrhagia: A retrospective cohort study
por: Nakamura, Kohei, et al.
Publicado: (2017)

Mucinous borderline ovarian tumors with BRAF(V600E) mutation may have low risk for progression to invasive carcinomas
por: Ohnishi, Kaori, et al.
Publicado: (2020)

Letrozole as second-line hormonal treatment for recurrent low-grade endometrial stromal sarcoma: A case report and review of the literature
por: Nakamura, Kohei, et al.
Publicado: (2016)

Preoperative tumor size is associated with deep myometrial invasion and lymph node metastases and is a negative prognostic indicator for patients with endometrial carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2018)

Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients
por: Ishikawa, Masako, et al.
Publicado: (2018)

Ultrasound-guided intranodal lymphangiography with lipiodol for treatment of chylous ascites following surgery for ovarian cancer: A case report
por: Nakamura, Kohei, et al.
Publicado: (2018)

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
por: Nakamura, Kohei, et al.
Publicado: (2016)

High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2018)

Efficacy of microwave ablation for the treatment of endometrial carcinoma: A report of 3 cases
por: NAKAMURA, KOHEI, et al.
Publicado: (2016)

Prognostic significance of pre-treatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in non-surgically treated uterine cervical carcinoma
por: Nakamura, Kohei, et al.
Publicado: (2018)

Genetic analysis and phosphoinositide 3-kinase/protein kinase B signaling pathway status in ovarian endometrioid borderline tumor samples
por: Nakamura, Kohei, et al.
Publicado: (2018)

Lynch Syndrome-Related Clear Cell Carcinoma of the Cervix: A Case Report
por: Nakamura, Kohei, et al.
Publicado: (2018)

Pregnancy by Assisted Reproductive Technology Is Associated with Shorter Telomere Length in Neonates
por: Minamoto, Toshiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mbc9vtrh1ejhh8720d6ap13k75